financetom
Business
financetom
/
Business
/
PagerDuty Fiscal Q4 Non-GAAP Earnings, Revenue Rise; Fiscal 2025 Guidance Set -- Shares Slide After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PagerDuty Fiscal Q4 Non-GAAP Earnings, Revenue Rise; Fiscal 2025 Guidance Set -- Shares Slide After Hours
Mar 14, 2024 2:05 PM

04:32 PM EDT, 03/14/2024 (MT Newswires) -- PagerDuty ( PD ) reported fiscal Q4 non-GAAP earnings late Thursday of $0.17 per diluted share, up from $0.07 a year earlier.

Analysts surveyed by Capital IQ expected $0.15.

Revenue for the quarter ended Jan. 31 was $111.1 million, up from $101 million a year earlier.

Analysts surveyed by Capital IQ expected $110.4 million.

The company said it expects fiscal Q1 non-GAAP EPS of $0.12 to $0.13. Analysts surveyed by Capital IQ expect $0.18. The company expects revenue for the quarter of $110.5 million to $112.5 million. Analysts surveyed by Capital IQ expect $113.4 million.

PagerDuty ( PD ) expects fiscal 2025 non-GAAP EPS of $0.65 to $0.70. Analysts surveyed by Capital IQ expect $0.82. The company expects revenue for the year of $470 million to $478 million. Analysts surveyed by Capital IQ expect $480.9 million.

Company shares were down 10% in after-hours activity.

Price: 20.66, Change: -2.27, Percent Change: -9.9

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eli Lilly Says Tirzepatide 'Significantly' Decreases Diabetes Progression Risk
Eli Lilly Says Tirzepatide 'Significantly' Decreases Diabetes Progression Risk
Aug 20, 2024
02:21 PM EDT, 08/20/2024 (MT Newswires) -- Eli Lilly ( LLY ) said Tuesday that Tirzepatide significantly lowered the risk of progression to type-2 diabetes in obese or overweight adults, based on data from a three-year study. Tirzepatide is approved in the US as Mounjaro for adults with type-2 diabetes and as Zepbound for obese or overweight adults. Weekly injections...
Why Richtech Robotics Stock Is Up Today
Why Richtech Robotics Stock Is Up Today
Aug 20, 2024
Richtech Robotics Inc. ( RR ) shares are trading higher Tuesday after the company announced the installation of its ADAM humanoid drink robot at a One Kitchen location inside a Rockford, Illinois Walmart.  The Details: The ADAM AI-enabled robot is expected to serve 100-200 cups of coffee and tea per day at the location. Richtech Robotics said this marks the second...
OpenAI signs deal with Condé Nast
OpenAI signs deal with Condé Nast
Aug 20, 2024
(Reuters) - OpenAI on Tuesday announced a deal with Condé Nast to display content from its brands such as the Vogue and the New Yorker within the AI startup's products, including ChatGPT and SearchGPT prototype. ...
Energix signs long-term solar power deal with Google
Energix signs long-term solar power deal with Google
Aug 20, 2024
(Reuters) - Energix Renewables said on Tuesday it has signed a long term agreement with Alphabet's Google to supply electricity and renewable energy credits generated from its solar projects to the tech giant. To power their rapidly expanding AI data centers, major technology firms like Google are increasingly negotiating electricity supply agreements with energy providers. Energix will initially supply 1.5...
Copyright 2023-2026 - www.financetom.com All Rights Reserved